Botulism pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 4: Line 4:


==Overview==
==Overview==
{{#ev:youtube|R-A8YI7Ik4g}}


==Microbiology==
==Microbiology==

Revision as of 20:35, 16 February 2012

Botulism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Botulism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Botulism pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Botulism pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Botulism pathophysiology

CDC on Botulism pathophysiology

Botulism pathophysiology in the news

Blogs on Botulism pathophysiology

Directions to Hospitals Treating Botulism

Risk calculators and risk factors for Botulism pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Michael Maddaleni, B.S.

Overview

{{#ev:youtube|R-A8YI7Ik4g}}

Microbiology

Clostridium botulinum is an obligate anaerobe that forms spores. The natural habitat for the Clostridium botulinum spores is the soil. The species of Clostridium botulinum is made up of 4 genetically diverse groups that do not have much in common other than the fact that they all produce the botulinum toxin[1]. The botulinum toxin itself exists as 7 different antigenic types and these 7 antigenic types have been assigned a series of letters: A, B, C, D, E, F, G[1]. These toxins have a specific definition, and they are defined by their inability to cross neutralize the other types. For example, Anti-A toxin can not neutralize any of the other toxin types (B-G). It should be noted that Clostridium baratii and Clostridium butyricum can also produce the botulinum toxin[1].

The botulinum molecule itself is composed of a heavy chain as well as a light chain polypeptide. It is referred to as a dichain polypeptide. The light chain of the toxin contains an endopeptidase that blocks acetylcholine-containing vesicles from being able to fuse with the membrane at the end of the motor neuron. If acetycholine is not present, it will result in flaccid muscle paralysis[1].

Many people may not realize it, but the commercial therapeutic procedure termed "Botox" actually contains the botulinum toxin. However, there is a very small amount of it present, otherwise it would present an extensive danger. A vial of type A preparation, which is currently licensed in the US, contains only about 0.005% of the lethal oral dose and 0.3% of the lethal inhalation dose[1].

Images

Video

{{#ev:youtube|Ug0L6pVdvoA}}

References

  1. 1.0 1.1 1.2 1.3 1.4 Arnon SS, Schechter R, Inglesby TV, Henderson DA, Bartlett JG, Ascher MS, Eitzen E, Fine AD, Hauer J, Layton M, Lillibridge S, Osterholm MT, O'Toole T, Parker G, Perl TM, Russell PK, Swerdlow DL, Tonat K (2001). "Botulinum toxin as a biological weapon: medical and public health management". JAMA : the Journal of the American Medical Association. 285 (8): 1059–70. PMID 11209178. Retrieved 2012-02-16. Unknown parameter |month= ignored (help)